Bharat Biotech International Limited - Product Pipeline Review - 2014

Published: Mar, 2014 | Pages: 41 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Bharat Biotech International Limited - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Bharat Biotech International Limited - Product Pipeline Review - 2014', provides an overview of the Bharat Biotech International Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bharat Biotech International Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Bharat Biotech International Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Bharat Biotech International Limited's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Bharat Biotech International Limited's pipeline products

Reasons to buy

- Evaluate Bharat Biotech International Limited's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Bharat Biotech International Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Bharat Biotech International Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Bharat Biotech International Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bharat Biotech International Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Bharat Biotech International Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Bharat Biotech International Limited Snapshot 5
Bharat Biotech International Limited Overview 5
Key Information 5
Key Facts 5
Bharat Biotech International Limited - Research and Development Overview 6
Key Therapeutic Areas 6
Bharat Biotech International Limited - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Bharat Biotech International Limited - Pipeline Products Glance 11
Bharat Biotech International Limited - Late Stage Pipeline Products 11
Pre-Registration Products/Combination Treatment Modalities 11
Phase III Products/Combination Treatment Modalities 12
Bharat Biotech International Limited - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Bharat Biotech International Limited - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Bharat Biotech International Limited - Drug Profiles 17
THR-100 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ORV-116E 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
lysostaphin 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Malaria Vaccine Program 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Vaccine For Plasmodium falciparum Infections 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Chikungunya Vaccine 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
FALVAC-1A 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Malaria Plamodium vivax Region II 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Recombinant Human Serum Albumin 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Staph Aureus Vaccine 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Acellular Pertussis Vaccine 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Human Papilloma Virus Vaccine 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Tetanus Vaccine 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Vaccine for Dengue Virus Infections 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Bharat Biotech International Limited - Pipeline Analysis 33
Bharat Biotech International Limited - Pipeline Products by Target 33
Bharat Biotech International Limited - Pipeline Products by Route of Administration 34
Bharat Biotech International Limited - Pipeline Products by Molecule Type 35
Bharat Biotech International Limited - Pipeline Products by Mechanism of Action 36
Bharat Biotech International Limited - Recent Pipeline Updates 37
Bharat Biotech International Limited - Dormant Projects 38
Bharat Biotech International Limited - Locations And Subsidiaries 39
Head Office 39
Appendix 40
Methodology 40
Coverage 40
Secondary Research 40
Primary Research 40
Expert Panel Validation 40
Contact Us 41
Disclaimer 41

List of Tables
Bharat Biotech International Limited, Key Information 5
Bharat Biotech International Limited, Key Facts 5
Bharat Biotech International Limited - Pipeline by Indication, 2014 8
Bharat Biotech International Limited - Pipeline by Stage of Development, 2014 9
Bharat Biotech International Limited - Monotherapy Products in Pipeline, 2014 10
Bharat Biotech International Limited - Pre-Registration, 2014 11
Bharat Biotech International Limited - Phase III, 2014 12
Bharat Biotech International Limited - Phase II, 2014 13
Bharat Biotech International Limited - Phase I, 2014 14
Bharat Biotech International Limited - Preclinical, 2014 15
Bharat Biotech International Limited - Discovery, 2014 16
Bharat Biotech International Limited - Pipeline by Target, 2014 33
Bharat Biotech International Limited - Pipeline by Route of Administration, 2014 34
Bharat Biotech International Limited - Pipeline by Molecule Type, 2014 35
Bharat Biotech International Limited - Pipeline Products by Mechanism of Action, 2014 36
Bharat Biotech International Limited - Recent Pipeline Updates, 2014 37
Bharat Biotech International Limited - Dormant Developmental Projects,2014 38